Alternatives to Adaptam Therapeutics
The top Biotech companies similar to Adaptam Therapeutics, ranked by relevance (named competitors first, then how closely their sectors overlap) and our 0-100 AI-readiness score. Each links to a full profile with funding and team.
Eleven Therapeutics55HealthcareLondon, United Kingdom$22.0M
Lembas Bio46Life SciencesCambridge, United States
Sakura Bio44Life SciencesCambridge, United States- BIBioForge Therapeutics29HealthTechPittsburgh, United States
Ipsen93BiotechParis, France
Immunai79HealthcareNew York, United States$315.0M
Moderna77BiotechnologyCambridge, United States$4.5B
VILYA63BIO + LIFE SCIENCESSan Francisco, United States$131.0M
Hexagon Bio62BiotechMenlo Park, United States$100.0M
TippingPoint Biosciences61BiotechCambridge, USA$14.5M- OMOmega Therapeutics61BiotechCambridge, United States
Mana.bio57Life SciencesBoston, United States$19.5M
Dinamo Biotechnologies55BiotechCambridge, United States
Orchard Therapeutics55BiotechBoston, United States$125.0M
ZipBio55Life SciencesCambridge, United States$4.0M
Arrakis Bio51Life SciencesCambridge, United States
Mustang Bio49BiotechWorcester, United States$150.0M- CSCSF Biosciences48BiotechCambridge, United States$15.0M
Paratus Sciences46BiotechNew York, United States
Gene Bio Medical45BiotechTel Aviv, Israel$10.0M
Goldenrod Therapeutics, .42BiotechSan Diego, United States$1.0M
VI Therapeutics42Life SciencesCambridge, United States
Wild Biotech38HealthcareCambridge, United States
EviCure37Life SciencesSan Diego, United States
QR Genetics32BiotechTel Aviv, Israel
DenovAI Biotech29Life SciencesRehovot, Israel
Genentech (Roche)BiotechSouth San Francisco, United States
Amgen85BiotechThousand Oaks, United States$40.0M
CytoReason79HealthcareTel Aviv, Israel$128.3M
Benchling74BIO + LIFE SCIENCESSan Francisco, United States$419.0M- DEDenali Therapeutics70BiotechSouth San Francisco, United States$1.0B
- ULUltragenyx70BiotechNovato, United States$100.0M
Triomics70BiotechCambridge, United States$22.0M
LabCorp69HealthTechBurlington, United States$2.9B
Adaptive Biotechnologies69BiotechSeattle, United States$300.0M
BeiGene67BiotechCambridge, United States$358.0M- LELexeo Therapeutics63BiotechNew York City, United States$495.0M
BioSymetrics63BiotechBoston, United States$6.6M
Amicus Therapeutics63BiotechPhiladelphia, United States$200.0M
Ukko63HealthcarePalo Alto, United States$50.0M
Somite.ai63Life SciencesTel Aviv, Israel$57.1M
Emendo Biotherapeutics63HealthcareTel Aviv, Israel$61.0M
Manifold Bio63BiotechBoston, United States$118.0M
Upstream Bio62Life SciencesWaltham, United States$450.0M
ParcelBio62BiotechnologySan Francisco, USA$100.0M
Cue Biopharma, .62BiotechBoston, United States$10.0M
Imagene62HealthcareTel Aviv, Israel$44.5M
Nona Biosciences62BiotechShanghai, China$100.0M
Moleculent61BiotechStockholm, Sweden$46.0M- RHRhythm Pharmaceuticals61BiotechBoston, United States
Deep Genomics61BiotechToronto, Canada$241.0M
Insitro61HealthcareSouth San Francisco, United States$243.0M
Nucleai61HealthcareTel Aviv, Israel$83.5M
CellCentric60BiotechnologyCambridge, United Kingdom$375.0M
Quartzy60BiotechnologyHayward, USA$40.0M
Harmony Biosciences Holdings57BiotechPlymouth Meeting, United States$400.5M
NeuroKaire57NeuroscienceTel Aviv, Israel$27.3M
Oncohost57HealthcareTel Aviv, Israel$43.0M
Protai57Life SciencesTel Aviv, Israel$20.0M
Converge Bio56Life SciencesSan Francisco, United States$5.5M
| Company | Sector | HQ | Funding | Score |
|---|---|---|---|---|
| Eleven Therapeutics | Healthcare | London, United Kingdom | $22.0M | 55 |
| Lembas Bio | Life Sciences | Cambridge, United States | — | 46 |
| Sakura Bio | Life Sciences | Cambridge, United States | — | 44 |
| BIBioForge Therapeutics | HealthTech | Pittsburgh, United States | — | 29 |
| Ipsen | Biotech | Paris, France | — | 93 |
| Immunai | Healthcare | New York, United States | $315.0M | 79 |
| Moderna | Biotechnology | Cambridge, United States | $4.5B | 77 |
| VILYA | BIO + LIFE SCIENCES | San Francisco, United States | $131.0M | 63 |
| Hexagon Bio | Biotech | Menlo Park, United States | $100.0M | 62 |
| TippingPoint Biosciences | Biotech | Cambridge, USA | $14.5M | 61 |
| OMOmega Therapeutics | Biotech | Cambridge, United States | — | 61 |
| Mana.bio | Life Sciences | Boston, United States | $19.5M | 57 |
| Dinamo Biotechnologies | Biotech | Cambridge, United States | — | 55 |
| Orchard Therapeutics | Biotech | Boston, United States | $125.0M | 55 |
| ZipBio | Life Sciences | Cambridge, United States | $4.0M | 55 |
| Arrakis Bio | Life Sciences | Cambridge, United States | — | 51 |
| Mustang Bio | Biotech | Worcester, United States | $150.0M | 49 |
| CSCSF Biosciences | Biotech | Cambridge, United States | $15.0M | 48 |
| Paratus Sciences | Biotech | New York, United States | — | 46 |
| Gene Bio Medical | Biotech | Tel Aviv, Israel | $10.0M | 45 |
| Goldenrod Therapeutics, . | Biotech | San Diego, United States | $1.0M | 42 |
| VI Therapeutics | Life Sciences | Cambridge, United States | — | 42 |
| Wild Biotech | Healthcare | Cambridge, United States | — | 38 |
| EviCure | Life Sciences | San Diego, United States | — | 37 |
| QR Genetics | Biotech | Tel Aviv, Israel | — | 32 |
| DenovAI Biotech | Life Sciences | Rehovot, Israel | — | 29 |
| Genentech (Roche) | Biotech | South San Francisco, United States | — | — |
| Amgen | Biotech | Thousand Oaks, United States | $40.0M | 85 |
| CytoReason | Healthcare | Tel Aviv, Israel | $128.3M | 79 |
| Benchling | BIO + LIFE SCIENCES | San Francisco, United States | $419.0M | 74 |
| DEDenali Therapeutics | Biotech | South San Francisco, United States | $1.0B | 70 |
| ULUltragenyx | Biotech | Novato, United States | $100.0M | 70 |
| Triomics | Biotech | Cambridge, United States | $22.0M | 70 |
| LabCorp | HealthTech | Burlington, United States | $2.9B | 69 |
| Adaptive Biotechnologies | Biotech | Seattle, United States | $300.0M | 69 |
| BeiGene | Biotech | Cambridge, United States | $358.0M | 67 |
| LELexeo Therapeutics | Biotech | New York City, United States | $495.0M | 63 |
| BioSymetrics | Biotech | Boston, United States | $6.6M | 63 |
| Amicus Therapeutics | Biotech | Philadelphia, United States | $200.0M | 63 |
| Ukko | Healthcare | Palo Alto, United States | $50.0M | 63 |
| Somite.ai | Life Sciences | Tel Aviv, Israel | $57.1M | 63 |
| Emendo Biotherapeutics | Healthcare | Tel Aviv, Israel | $61.0M | 63 |
| Manifold Bio | Biotech | Boston, United States | $118.0M | 63 |
| Upstream Bio | Life Sciences | Waltham, United States | $450.0M | 62 |
| ParcelBio | Biotechnology | San Francisco, USA | $100.0M | 62 |
| Cue Biopharma, . | Biotech | Boston, United States | $10.0M | 62 |
| Imagene | Healthcare | Tel Aviv, Israel | $44.5M | 62 |
| Nona Biosciences | Biotech | Shanghai, China | $100.0M | 62 |
| Moleculent | Biotech | Stockholm, Sweden | $46.0M | 61 |
| RHRhythm Pharmaceuticals | Biotech | Boston, United States | — | 61 |
| Deep Genomics | Biotech | Toronto, Canada | $241.0M | 61 |
| Insitro | Healthcare | South San Francisco, United States | $243.0M | 61 |
| Nucleai | Healthcare | Tel Aviv, Israel | $83.5M | 61 |
| CellCentric | Biotechnology | Cambridge, United Kingdom | $375.0M | 60 |
| Quartzy | Biotechnology | Hayward, USA | $40.0M | 60 |
| Harmony Biosciences Holdings | Biotech | Plymouth Meeting, United States | $400.5M | 57 |
| NeuroKaire | Neuroscience | Tel Aviv, Israel | $27.3M | 57 |
| Oncohost | Healthcare | Tel Aviv, Israel | $43.0M | 57 |
| Protai | Life Sciences | Tel Aviv, Israel | $20.0M | 57 |
| Converge Bio | Life Sciences | San Francisco, United States | $5.5M | 56 |